CBB-68

N/A

Report date: 2025/01/26 19:23:54
NME

Base Information

Drug NameCBB-68
Drug Alias Namebeta amyloid modulators (Crossbeta Biosciences)CBB-68
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossbeta Biosciences BV
China Registration ClassN/A

Develop Information

Active CompaniesCrossbeta Biosciences BV
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A